Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Cornea / Ocular Surface

New Protocols Rejuvenate Epi-On Cross-Linking

Epithelium-off (epi-off) CXL has been effective in halting the progression of keratoconus, offering hope to many patients with this progressive condition (1). Epithelium-on (epi-on) CXL, in which the epithelium is minimally disturbed, has historically not been as successful (2).

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Michael B. Raizman

Michael B. Raizman practices with Ophthalmic Consultants of Boston, is an associate professor of ophthalmology at Tufts University School of Medicine, and co-director of the Cornea and Cataract Service and director of the Corneal Fellowship at Tufts Medical Center.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register